A combined analysis of North American case-control studies of residential radon and lung cancer

D Krewski, JH Lubin, JM Zielinski… - Journal of Toxicology …, 2006 - Taylor & Francis
… Although our primary focus in the present analysis is on all types of lung cancer combined,
we also conducted analyses by histological subtypes of lung cancer. Of the 4081 cases in the …

K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases

M Huncharek, J Muscat, JF Geschwind - Carcinogenesis, 1999 - academic.oup.com
… Our combined analysis of almost 900 patients shows that k-ras mutations may be associated
with an almost doubled risk of death at 2 years from NSCLC. As discussed above, this …

Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer

RT Dess, Y Sun, MM Matuszak, G Sun… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Radiation therapy is a critical component in the care of patients with non–small-cell
lung cancer (NSCLC), yet cardiac injury after treatment is a significant concern. Therefore, …

Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies

D Krewski, JH Lubin, JM Zielinski, M Alavanja… - …, 2005 - journals.lww.com
lung cancer risks associated with radon in homes, we conducted a combined analysis of the
… case–control studies of residential radon and lung cancer, including studies in New Jersey, …

[HTML][HTML] Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non–small-cell lung cancer: combined analysis of two IFCT …

G Mouillet, E Monnet, B Milleron, M Puyraveau… - Journal of Thoracic …, 2012 - Elsevier
Introduction: Our study aimed to evaluate whether pathologic complete response (pCR) in
early-stage non–small-cell lung cancer (NSCLC) after neoadjuvant chemotherapy resulted in …

Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations

S Morita, I Okamoto, K Kobayashi, K Yamazaki… - Clinical Cancer …, 2009 - AACR
… In conclusion, our combined analysis of updated individual patient data from seven Japanese
phase II trials confirmed that gefitinib monotherapy yields substantial clinical benefits in …

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta‐analysis

P Marino, A Preatoni, A Cantoni - Cancer, 1995 - Wiley Online Library
analysis does not show an advantage for combined therapy. … Meta-analysis could be useful
in all cases in which conflicting … The current meta-analysis study suggests that combined

Combined analysis of estrogen receptor β-1 and progesterone receptor expression identifies lung cancer patients with poor outcome

LP Stabile, S Dacic, SR Land, DE Lenzner, R Dhir… - Clinical Cancer …, 2011 - AACR
… treatment strategies for lung cancer. This work examines the combined effect of expression
of estrogen receptor β-1 and progesterone receptor in tissues from lung cancer patients and …

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials

J Treat, GV Scagliotti, G Peng, MJ Monberg… - Lung cancer, 2012 - Elsevier
… The primary objective of the current combined analysis of three large phase 3 trials was
to determine the comparability (overall and by histology) of pemetrexed–cisplatin with other …

Smoking and lung cancer in China: combined analysis of eight case-control studies

Z Liu - International journal of epidemiology, 1992 - academic.oup.com
… between lung cancer and smoking and in the present paper, a combined analysis of eight
… , and attributable risk (AR) of lung cancer associated with smoking were calculated from the …